Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma

Background and Objective: The primary goal of this study is to develop a rigorous understanding ofthe correlation between COX-2 expression and malignant melanoma prognostic factors. Material and Methods: In this cross-sectional study, we analyzed 60 cases of cutaneous malignant melanoma. The related...

Full description

Bibliographic Details
Main Authors: Amir Hossein Jafarian, Nema Mohammadian Roshan, Masoumeh Gharib, Vahid Moshirahmadi, Aida Tasbandi, Amir Ali Ayatollahi, Hossein Ayatollahi
Format: Article
Language:English
Published: Iranian Society of Pathology 2019-04-01
Series:Iranian Journal of Pathology
Subjects:
Online Access:https://ijp.iranpath.org/article_35536_ccbba5d6642fb9e9331fa1eba71d5d77.pdf
_version_ 1819095412367163392
author Amir Hossein Jafarian
Nema Mohammadian Roshan
Masoumeh Gharib
Vahid Moshirahmadi
Aida Tasbandi
Amir Ali Ayatollahi
Hossein Ayatollahi
author_facet Amir Hossein Jafarian
Nema Mohammadian Roshan
Masoumeh Gharib
Vahid Moshirahmadi
Aida Tasbandi
Amir Ali Ayatollahi
Hossein Ayatollahi
author_sort Amir Hossein Jafarian
collection DOAJ
description Background and Objective: The primary goal of this study is to develop a rigorous understanding ofthe correlation between COX-2 expression and malignant melanoma prognostic factors. Material and Methods: In this cross-sectional study, we analyzed 60 cases of cutaneous malignant melanoma. The related stained slides were reviewed by two pathologists. The results were interpreted according to the COX2 staining index (SI), tumor thickness (Breslow, Clark), number of mitoses per 10 hpf, and melanoma types. Gender, lymph node involvement, metastasis, and survival were considered as evaluation factors as well.  Results: The expression of the COX-2 protein was evident in 98.4% of cases. A strong Staining Index(SI) was reported in 60% of all melanomas, moderate staining was detected in 20.8% and weak staining in 10%; 1.6% of studied cases showed no staining. Benign nevus specimens showed no staining for the COX-2 enzyme. Conclusion: We have demonstrated that COX-2 is strongly expressed in the majority of malignant melanomas and that the SI score of COX-2 is related to the number of mitoses, tumor thickness (based on Clark level and Breslow), melanoma sub-type, lymph node involvement, and metastases; No association was noted between the anatomic site, gender, and survival. COX-2 can be applied as a prognostic factor in malignant melanoma and a promising candidate for future target therapies.
first_indexed 2024-12-21T23:42:53Z
format Article
id doaj.art-8a236989aa644e4db3c1220e44661d4f
institution Directory Open Access Journal
issn 1735-5303
2345-3656
language English
last_indexed 2024-12-21T23:42:53Z
publishDate 2019-04-01
publisher Iranian Society of Pathology
record_format Article
series Iranian Journal of Pathology
spelling doaj.art-8a236989aa644e4db3c1220e44661d4f2022-12-21T18:46:12ZengIranian Society of PathologyIranian Journal of Pathology1735-53032345-36562019-04-011429610310.30699/ijp.14.2.9635536Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant MelanomaAmir Hossein Jafarian0Nema Mohammadian Roshan1Masoumeh Gharib2Vahid Moshirahmadi3Aida Tasbandi4Amir Ali Ayatollahi5Hossein Ayatollahi6Associate Professor of Pathology, Department Of Pathology, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranAssociate Professor of Pathology, Department Of Pathology, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranAssistant Professor of Pathology, Department Of Pathology, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranCancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranCancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranCancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranAssociate Professor of Pathology, Department Of Pathology, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranBackground and Objective: The primary goal of this study is to develop a rigorous understanding ofthe correlation between COX-2 expression and malignant melanoma prognostic factors. Material and Methods: In this cross-sectional study, we analyzed 60 cases of cutaneous malignant melanoma. The related stained slides were reviewed by two pathologists. The results were interpreted according to the COX2 staining index (SI), tumor thickness (Breslow, Clark), number of mitoses per 10 hpf, and melanoma types. Gender, lymph node involvement, metastasis, and survival were considered as evaluation factors as well.  Results: The expression of the COX-2 protein was evident in 98.4% of cases. A strong Staining Index(SI) was reported in 60% of all melanomas, moderate staining was detected in 20.8% and weak staining in 10%; 1.6% of studied cases showed no staining. Benign nevus specimens showed no staining for the COX-2 enzyme. Conclusion: We have demonstrated that COX-2 is strongly expressed in the majority of malignant melanomas and that the SI score of COX-2 is related to the number of mitoses, tumor thickness (based on Clark level and Breslow), melanoma sub-type, lymph node involvement, and metastases; No association was noted between the anatomic site, gender, and survival. COX-2 can be applied as a prognostic factor in malignant melanoma and a promising candidate for future target therapies.https://ijp.iranpath.org/article_35536_ccbba5d6642fb9e9331fa1eba71d5d77.pdfmalignant melanomacox-2prognostic factors
spellingShingle Amir Hossein Jafarian
Nema Mohammadian Roshan
Masoumeh Gharib
Vahid Moshirahmadi
Aida Tasbandi
Amir Ali Ayatollahi
Hossein Ayatollahi
Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
Iranian Journal of Pathology
malignant melanoma
cox-2
prognostic factors
title Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
title_full Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
title_fullStr Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
title_full_unstemmed Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
title_short Evaluation of Cyclooxygenase-2 Expression in Association with Clinical-Pathological Factors in Malignant Melanoma
title_sort evaluation of cyclooxygenase 2 expression in association with clinical pathological factors in malignant melanoma
topic malignant melanoma
cox-2
prognostic factors
url https://ijp.iranpath.org/article_35536_ccbba5d6642fb9e9331fa1eba71d5d77.pdf
work_keys_str_mv AT amirhosseinjafarian evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT nemamohammadianroshan evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT masoumehgharib evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT vahidmoshirahmadi evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT aidatasbandi evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT amiraliayatollahi evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma
AT hosseinayatollahi evaluationofcyclooxygenase2expressioninassociationwithclinicalpathologicalfactorsinmalignantmelanoma